Team:HKUST-Hong Kong/Parts and Device
From 2012.igem.org
m (Formatting and Grammar) |
|||
Line 368: | Line 368: | ||
<p>The HKUST iGEM 2012 team has submitted 18 BioBricks in total. <b><a href="https://static.igem.org/mediawiki/2012/7/73/Parts_and_Device.pdf" target="_blank">A full list of BioBricks</a></b> has been attached with this page.<br> | <p>The HKUST iGEM 2012 team has submitted 18 BioBricks in total. <b><a href="https://static.igem.org/mediawiki/2012/7/73/Parts_and_Device.pdf" target="_blank">A full list of BioBricks</a></b> has been attached with this page.<br> | ||
- | <br>For the Target Binding module, two BioBricks were built to display the colon tumor recognition peptide, RPMrel, on the cell wall of <i>B. subtilis</i>. In the Anti-tumor Molecule | + | <br>For the Target Binding module, two BioBricks were built to display the colon tumor recognition peptide, RPMrel, on the cell wall of <i>B. subtilis</i>. In the Anti-tumor Molecule Secretion module, two BioBricks are built for BMP2 synthesis and secretion while the other five were built to facilitate the accomplishment of BMP2 synthesis. 11 BioBricks are built for the Regulation and Control module. They are mainly used to drive the toxin-antitoxin system, which controls the expression of BMP2.<b><a href="https://static.igem.org/mediawiki/2012/e/ee/Sorted_by_Module.pdf" target="_blank"> They are sorted by module as shown in this page.</a></b><br> |
<br>Among all 18 parts, three of them are well characterized. They are <u><a href="http://partsregistry.org/Part:BBa_K733009">BBa_K733009</a></u>, a GFP generator driven by <i>Ptms</i> promoter; <u><a href="http://partsregistry.org/Part:BBa_K733018" target="_blank">BBa_K733018</a></u>, a GFP generator driven by xylose inducible promoter and <u><a href="http://partsregistry.org/Part:BBa_K733012" target="_blank">BBa_K733012</a></u>, the cell growth inhibition device. For detailed <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Characterization">characterization data</a> please refer to the information of these three BioBricks or our Characterization section on the wiki.<br> | <br>Among all 18 parts, three of them are well characterized. They are <u><a href="http://partsregistry.org/Part:BBa_K733009">BBa_K733009</a></u>, a GFP generator driven by <i>Ptms</i> promoter; <u><a href="http://partsregistry.org/Part:BBa_K733018" target="_blank">BBa_K733018</a></u>, a GFP generator driven by xylose inducible promoter and <u><a href="http://partsregistry.org/Part:BBa_K733012" target="_blank">BBa_K733012</a></u>, the cell growth inhibition device. For detailed <a href="https://2012.igem.org/Team:HKUST-Hong_Kong/Characterization">characterization data</a> please refer to the information of these three BioBricks or our Characterization section on the wiki.<br> |
Revision as of 17:50, 26 September 2012
Parts and Devices
Overview
The HKUST iGEM 2012 team has submitted 18 BioBricks in total. A full list of BioBricks has been attached with this page.
For the Target Binding module, two BioBricks were built to display the colon tumor recognition peptide, RPMrel, on the cell wall of B. subtilis. In the Anti-tumor Molecule Secretion module, two BioBricks are built for BMP2 synthesis and secretion while the other five were built to facilitate the accomplishment of BMP2 synthesis. 11 BioBricks are built for the Regulation and Control module. They are mainly used to drive the toxin-antitoxin system, which controls the expression of BMP2. They are sorted by module as shown in this page.
Among all 18 parts, three of them are well characterized. They are BBa_K733009, a GFP generator driven by Ptms promoter; BBa_K733018, a GFP generator driven by xylose inducible promoter and BBa_K733012, the cell growth inhibition device. For detailed characterization data please refer to the information of these three BioBricks or our Characterization section on the wiki.
For the convenience of other parties in using and searching for BioBricks, we also sorted our BioBricks based on their type. For detailed information please access this link.
Construction >>>
Project
Human Practice